Valeant Pharmaceuticals reported $814M in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amgen AMGN:US USD 2.23B 508M
Ani Pharmaceuticals ANIP:US USD -4995000 7.92M
Aurora Cannabis Inc ACB:CN CAD -54500000 570.08M
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 1.94B 528M
Canopy Growth Corp WEED:CN CAD -159665000 1.7B
Catalent CTLT:US USD 60M 186M
Corcept Therapeutics CORT:US USD 31.93M 502K
Danaher DHR:US USD 2.3B 281M
Drreddys Laboratories RDY:US INR 16.42B 298M
Eli Lilly And LLY:US USD 1.84B 159.9M
Endo International Ordinary Shares ENDP:US USD -636822000 1.1B
Gilead Sciences GILD:US USD 2.27B 570M
Horizon Pharma HZNP:US USD 160.61M 72.05M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Pacira Pharmaceuticals PCRX:US USD 21.29M 9.95M
Perrigo Ordinary Shares PRGO:US USD 33.5M 49.7M
Prestige Brands PBH:US USD 84.38M 2.63M
Revance Therapeutics RVNC:US USD -77484000 19.64M
Supernus Pharmaceuticals SUPN:US USD -1523000 12.87M
Valeant Pharmaceuticals VRX:CN USD 814M 540M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
Zoetis ZTS:US USD 667M 3M